Change in the pharmaceutical industry is imminent. Pharmaceutical companies are juggling expiring drug-patents, increasing competition from generic drugs and a shrinking product pipeline. The tightening and decline in the industry is encouraging a culture of consolidation and the frequency of large mergers is adding to the uncertain atmosphere.
InVentiv Advance Insights, a leading provider of commercialization solutions for the healthcare and pharmaceutical industry have risen to meet this challenge. Utilizing innovation and technology to build their bottom line and add further value to their client offerings.
Maximising how much profit or cost saving is realized from an investment is increasingly important in any environment, and ROI has become especially important since the global economy has started to show signs of economic recovery.